Valuation: Guided Therapeutics Inc

Market Cap 28.96M 25.41M 23.45M 21.65M 41.03M 2.76B 41.74M 281M 110M 1.36B 109M 106M 4.69B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 31.84M 27.93M 25.78M 23.8M 45.1M 3.04B 45.88M 308M 121M 1.49B 120M 117M 5.16B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 05/03/2023
Chief Tech/Sci/R&D Officer 70 01/12/2010
Director TitleAgeSince
Director/Board Member 76 09/04/2006
Director/Board Member 69 09/11/2016
Director/Board Member 70 30/11/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%+0.69%+21.20%+1.50% 196B
-1.16%-4.51%-20.56%+19.96% 144B
+1.57%+0.57%-2.83%-16.25% 141B
-0.49%-0.82%-56.62%-14.64% 66.54B
+0.96%-2.29%+18.14%-0.25% 53.09B
+0.61%-1.09%-24.93%-30.81% 44.12B
+0.52%+2.75%+8.93%+13.34% 37.93B
-0.19%-0.75%+6.66%+42.84% 36.96B
0.00%-1.32%-13.88%-20.38% 29.43B
Average +0.25%-0.84%-7.10%-0.52% 83.21B
Weighted average by Cap. +0.27%-0.96%-3.92%+0.03%

Financials

2024 2025
Net sales 7K 6.14K 5.67K 5.23K 9.92K 668K 10.09K 67.8K 26.6K 328K 26.28K 25.71K 1.13M 767K 673K 621K 573K 1.09M 73.15M 1.11M 7.43M 2.92M 35.91M 2.88M 2.82M 124M
Net income -2.42M -2.12M -1.96M -1.81M -3.42M -231M -3.48M -23.41M -9.19M -113M -9.07M -8.88M -392M -3.2M -2.8M -2.59M -2.39M -4.53M -305M -4.61M -30.96M -12.15M -150M -12M -11.74M -518M
Net Debt 1.77M 1.55M 1.43M 1.32M 2.51M 169M 2.55M 17.15M 6.73M 82.92M 6.65M 6.5M 287M 2.88M 2.52M 2.33M 2.15M 4.07M 274M 4.14M 27.86M 10.93M 135M 10.8M 10.56M 466M
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-